Baricitinib Shows Superior Efficacy Versus Traditional Alopecia Treatments
Dermatology Times
NOVEMBER 25, 2024
The JAK inhibitor was significantly superior in all safety and efficacy endpoints, when compared to other AA treatment options.
Dermatology Times
NOVEMBER 25, 2024
The JAK inhibitor was significantly superior in all safety and efficacy endpoints, when compared to other AA treatment options.
Skin Inc
NOVEMBER 25, 2024
spa news, spa industry news, skin care news, skin care tips, spa openings, spa franchise, spa anniversary, spa education, spa training
US Dermatologt Partners
NOVEMBER 25, 2024
While melanoma is a relatively rare form of skin cancer, the number of melanoma cases diagnosed has increased over the past several decades. Despite more overall cases, the melanoma mortality rate has decreased, in part due to earlier diagnosis. According to Dr. Yanes of U.S. Dermatology Partners Annapolis , “Early diagnosis is key to successfully treating melanoma.
Skin Inc
NOVEMBER 25, 2024
spa news, spa industry news, skin care news, skin care tips, spa openings, spa franchise, spa anniversary, spa education, spa training
Lipgloss and Aftershave
NOVEMBER 25, 2024
Video Recap of AAAM (American Academy of Aesthetic Medicine) L+A attended AAAM Orlando on November 8th and 9th, where L+A Medical Editor, Dr. Chantal Lunderville was presenting. We had the opportunity to interview seven physicians who are part of the AAAM International Faculty. We’ve created a compilation of all of these interviews to share with the L+A Community.
Dermatology Times
NOVEMBER 25, 2024
Catch up on coverage from the 22nd annual Society of Dermatology Physician Associates Fall Dermatology Conference in Las Vegas, Nevada.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
NOVEMBER 25, 2024
Researchers recommend limiting routine lipase tests to symptomatic patients or those with radiographic signs of pancreatic injury.
Dermatology Times
NOVEMBER 25, 2024
Panelists discuss how setting long-term treatment goals for basal cell carcinoma (BCC) patients involves balancing factors such as disease control, quality of life, and potential adverse reactions to create personalized management plans that address both immediate concerns and future outcomes.
Dermatology Times
NOVEMBER 25, 2024
Certain factors may contribute to higher occurrences of non-melanoma skin cancer in these patients, according to a novel systemic review.
Dermatology Times
NOVEMBER 25, 2024
According to the company, comparative tests revealed PN-881 surpasses or matches the efficacy of current injectable IL-17 therapies.
Let's personalize your content